nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A rationally designed form of the TLR5 agonist, flagellin, supports superior immunogenicity of Influenza B globular head vaccines
|
Song, Langzhou |
|
2014 |
32 |
34 |
p. 4317-4323 7 p. |
artikel |
2 |
Are we there yet? Assessing achievement of vaccine-preventable disease goals in WHO's Western Pacific Region
|
Hennessey, Karen |
|
2014 |
32 |
34 |
p. 4259-4266 8 p. |
artikel |
3 |
Association between human papillomavirus vaccine status and other cervical cancer risk factors
|
Bowyer, Harriet L. |
|
2014 |
32 |
34 |
p. 4310-4316 7 p. |
artikel |
4 |
A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice
|
Ku, Zhiqiang |
|
2014 |
32 |
34 |
p. 4296-4303 8 p. |
artikel |
5 |
Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: Are all delivery methods the same?
|
Levin, Yotam |
|
2014 |
32 |
34 |
p. 4249-4252 4 p. |
artikel |
6 |
Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2
|
Opriessnig, Tanja |
|
2014 |
32 |
34 |
p. 4342-4348 7 p. |
artikel |
7 |
Editorial Board/Aims and Scope
|
|
|
2014 |
32 |
34 |
p. IFC- 1 p. |
artikel |
8 |
Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs
|
Woolley, Lauren K. |
|
2014 |
32 |
34 |
p. 4333-4341 9 p. |
artikel |
9 |
Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays
|
Yamanaka, Atsushi |
|
2014 |
32 |
34 |
p. 4289-4295 7 p. |
artikel |
10 |
Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety
|
Beran, Jiří |
|
2014 |
32 |
34 |
p. 4275-4280 6 p. |
artikel |
11 |
Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice
|
Feunou, Pascal F. |
|
2014 |
32 |
34 |
p. 4281-4288 8 p. |
artikel |
12 |
Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing
|
Tyler, Mitchell |
|
2014 |
32 |
34 |
p. 4267-4274 8 p. |
artikel |
13 |
Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection
|
Trentini, Monalisa Martins |
|
2014 |
32 |
34 |
p. 4324-4332 9 p. |
artikel |
14 |
Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England
|
van Hoek, Albert Jan |
|
2014 |
32 |
34 |
p. 4349-4355 7 p. |
artikel |
15 |
Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal
|
Upreti, Shyam Raj |
|
2014 |
32 |
34 |
p. 4304-4309 6 p. |
artikel |
16 |
Recent progress and concerns regarding the Japanese immunization program: Addressing the “vaccine gap”
|
Saitoh, Akihiko |
|
2014 |
32 |
34 |
p. 4253-4258 6 p. |
artikel |
17 |
Report of the Third European Expert Meeting on Rotavirus Vaccination: Progress in rotavirus universal mass vaccination in Europe
|
Huppertz, HI |
|
2014 |
32 |
34 |
p. 4243-4248 6 p. |
artikel |
18 |
Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999–2010
|
Lamb, Karen E. |
|
2014 |
32 |
34 |
p. 4356-4363 8 p. |
artikel |